Literature DB >> 8917709

Neoplastic human tissue mast cells express the adhesion molecule CD44/HCAM.

H P Horny1, D M Menke, E Kaiserling.   

Abstract

Expression of the homing-associated cell adhesion molecule/HCAM (CD44) in normal/reactive and neoplastic human tissue mast cells (TMC) was determined immunohistochemically using the antibody DAKO-DF1485, which detects all isoforms of CD44. Studies were performed on 30 routinely processed specimens. Twenty of these, from bone marrow, skin, spleen, liver, lymph node and jejunal mucosa, contained infiltrates of TMC. These represented various types of generalized mastocytosis/systemic mast cell disease, including benign systemic mastocytosis. Ten specimens consisted of tissue with a marked reactive increase in TMC; most of these were lymph nodes with chronic nonspecific lymphadenitis and benign or malignant solid tumours. In all 30 specimens TMC exhibited an annular pattern of immunostaining, which was usually very strong. Both normal/reactive and neoplastic TMC exhibited consistent immunoreactivity with the antibody DAKO-DF1485, and this antibody may be of diagnostic value in the detection of atypical TMC associated with malignant mastocytosis. TMC and their neoplastic derivatives belong to a large family of mesenchymal and epithelial cells containing the principal surface receptor for hyaluronan.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917709     DOI: 10.1007/bf00192430

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  Differential expression of cell surface integrins on human mast cells and human basophils.

Authors:  W R Sperr; H Agis; K Czerwenka; W Klepetko; E Kubista; G Boltz-Nitulescu; K Lechner; P Valent
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

2.  Bone marrow findings in systemic mastocytosis.

Authors:  H P Horny; M R Parwaresch; K Lennert
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 4.  Mast cells: function and contents.

Authors:  L B Schwartz
Journal:  Curr Opin Immunol       Date:  1994-02       Impact factor: 7.486

5.  Lymph node findings in generalized mastocytosis.

Authors:  H P Horny; E Kaiserling; M R Parwaresch; K Lennert
Journal:  Histopathology       Date:  1992-11       Impact factor: 5.087

6.  Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study.

Authors:  H P Horny; E Kaiserling
Journal:  Br J Haematol       Date:  1988-08       Impact factor: 6.998

7.  CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.

Authors:  R Stauder; W Eisterer; J Thaler; U Günthert
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

8.  Further characterization of surface membrane structures expressed on human basophils and mast cells.

Authors:  P Valent; O Majdic; D Maurer; M Bodger; M Muhm; P Bettelheim
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

9.  The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.

Authors:  W R Sperr; H C Bankl; G Mundigler; G Klappacher; K Grossschmidt; H Agis; P Simon; P Laufer; M Imhof; T Radaszkiewicz; D Glogar; K Lechner; P Valent
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

10.  Stem cell factor is a chemotactic factor for human mast cells.

Authors:  G Nilsson; J H Butterfield; K Nilsson; A Siegbahn
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

View more
  4 in total

1.  Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Authors:  Vera S Donnenberg; Albert D Donnenberg; Ludovic Zimmerlin; Rodney J Landreneau; Rohit Bhargava; Ryan A Wetzel; Per Basse; Adam M Brufsky
Journal:  Cytometry B Clin Cytom       Date:  2010-04-30       Impact factor: 3.058

2.  Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates.

Authors:  Ludovic Zimmerlin; Albert D Donnenberg; J Peter Rubin; Per Basse; Rodney J Landreneau; Vera S Donnenberg
Journal:  Tissue Eng Part A       Date:  2010-09-17       Impact factor: 3.845

3.  Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis.

Authors:  S Seitz; F Barvencik; T Koehne; M Priemel; P Pogoda; J Semler; H Minne; M Pfeiffer; J Zustin; K Püschel; C Eulenburg; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2013-02-23       Impact factor: 4.507

4.  CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.

Authors:  Niklas Mueller; Daniel Wicklein; Gregor Eisenwort; Mohamad Jawhar; Daniela Berger; Gabriele Stefanzl; Georg Greiner; Alexandra Boehm; Christoph Kornauth; Leonhard Muellauer; Susanne Sehner; Gregor Hoermann; Wolfgang R Sperr; Philipp B Staber; Ulrich Jaeger; Johannes Zuber; Michel Arock; Udo Schumacher; Andreas Reiter; Peter Valent
Journal:  Blood       Date:  2018-07-17       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.